-
1
-
-
0032746704
-
Microalbuminuria in essential hypertension: Significance, pathophysiology, and therapeutic implications
-
Bianchi S, Bigazzi R, Campese VM. Microalbuminuria in essential hypertension: Significance, pathophysiology, and therapeutic implications. Am J Kidney Dis 1999;34:973-95.
-
(1999)
Am J Kidney Dis
, vol.34
, pp. 973-995
-
-
Bianchi, S.1
Bigazzi, R.2
Campese, V.M.3
-
2
-
-
0006415693
-
Clinical value of microalbuminuria in hypertension
-
Rosa TT, Palatini P. Clinical value of microalbuminuria in hypertension. J Hypertens 2000;18:645-54.
-
(2000)
J Hypertens
, vol.18
, pp. 645-654
-
-
Rosa, T.T.1
Palatini, P.2
-
3
-
-
0000116576
-
Relation of office and home blood pressure to left ventricular hypertrophy and performance in patients with hypertension
-
Abe H, Yokouchi M, Nagata S, Ashida T, Yoshimi H, Kawano Y, et al. Relation of office and home blood pressure to left ventricular hypertrophy and performance in patients with hypertension. High Blood Press 1992;1:279-85.
-
(1992)
High Blood Press
, vol.1
, pp. 279-285
-
-
Abe, H.1
Yokouchi, M.2
Nagata, S.3
Ashida, T.4
Yoshimi, H.5
Kawano, Y.6
-
4
-
-
0033931318
-
Prognostic significance of self-measurements of blood pressure
-
Imai Y, Poncelet P, DeBuyzere M, Padfield PL, Van Montfrans GA. Prognostic significance of self-measurements of blood pressure. Blood Press Monit 2000;5:137-43.
-
(2000)
Blood Press Monit
, vol.5
, pp. 137-143
-
-
Imai, Y.1
Poncelet, P.2
DeBuyzere, M.3
Padfield, P.L.4
Van Montfrans, G.A.5
-
5
-
-
0005158182
-
-
Japanese source
-
-
-
-
6
-
-
0032810395
-
Elevated systolic blood pressure as a risk factor for cardiovascular and renal disease
-
He J, Whelton PK. Elevated systolic blood pressure as a risk factor for cardiovascular and renal disease. J Hypertens 1999;17(Suppl 2):S7-13.
-
(1999)
J Hypertens
, vol.17
, Issue.SUPPL. 2
-
-
He, J.1
Whelton, P.K.2
-
7
-
-
0028151603
-
Ambulatory 24-hour blood pressure versus self-measured blood pressure in pharmacologic trials
-
Mengden T, Weisser B, Vetter V. Ambulatory 24-hour blood pressure versus self-measured blood pressure in pharmacologic trials. J Cardiovasc Pharmacol 1994; 24(Suppl 2):S20-5.
-
(1994)
J Cardiovasc Pharmacol
, vol.24
, Issue.SUPPL. 2
-
-
Mengden, T.1
Weisser, B.2
Vetter, V.3
-
8
-
-
0031843971
-
Effects of magnesium supplementation in hypertensive patients: Assessment by office, home, and ambulatory blood pressures
-
Kawano Y, Matsuoka H, Takishita S, Omae T. Effects of magnesium supplementation in hypertensive patients: Assessment by office, home, and ambulatory blood pressures. Hypertension 1998;32:260-5.
-
(1998)
Hypertension
, vol.32
, pp. 260-265
-
-
Kawano, Y.1
Matsuoka, H.2
Takishita, S.3
Omae, T.4
-
10
-
-
0027235343
-
Microalbuminuria in essential hypertension: Reduction by different antihypertensive drugs
-
Erley CM, Haefere U, Heyne N, Braun N, Risler T. Microalbuminuria in essential hypertension: Reduction by different antihypertensive drugs. Hypertension 1993;21:810-5.
-
(1993)
Hypertension
, vol.21
, pp. 810-815
-
-
Erley, C.M.1
Haefere, U.2
Heyne, N.3
Braun, N.4
Risler, T.5
-
11
-
-
0035110009
-
Does treatment of non-malignant hypertension reduce the incidence of renal dysfunction? : A meta-analysis of 10 randomized, controlled trials
-
Hsu CY. Does treatment of non-malignant hypertension reduce the incidence of renal dysfunction? : A meta-analysis of 10 randomized, controlled trials. J Hum Hypertens 2001;15:99-106.
-
(2001)
J Hum Hypertens
, vol.15
, pp. 99-106
-
-
Hsu, C.Y.1
-
12
-
-
0035816018
-
Effect of ramipril vs amlodipine on renal outcomes in hypertensive nephrosclerosis: A randomized controlled trial
-
Agodoa LY, Appel L, Bakris GL, Beck G, Bourgoignie J, Briggs JP, et al. Effect of ramipril vs amlodipine on renal outcomes in hypertensive nephrosclerosis: A randomized controlled trial. JAMA 2001;285:2719-28.
-
(2001)
JAMA
, vol.285
, pp. 2719-2728
-
-
Agodoa, L.Y.1
Appel, L.2
Bakris, G.L.3
Beck, G.4
Bourgoignie, J.5
Briggs, J.P.6
-
13
-
-
0035922441
-
Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy
-
Brenner BM, Cooper ME, de Zeeuw D, Keane WF, Mitch WE, Parving HH, et al. Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. N Engl J Med 2001;345:861-9.
-
(2001)
N Engl J Med
, vol.345
, pp. 861-869
-
-
Brenner, B.M.1
Cooper, M.E.2
De Zeeuw, D.3
Keane, W.F.4
Mitch, W.E.5
Parving, H.H.6
-
14
-
-
0035922447
-
Renoprotective effect of the angiotensin receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes
-
Lewis EJ, Hunsicker LG, Clarke WR, Berl T, Pohl MA, Lewis JB, et al. Renoprotective effect of the angiotensin receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes. N Engl J Med 2001;345:851-60.
-
(2001)
N Engl J Med
, vol.345
, pp. 851-860
-
-
Lewis, E.J.1
Hunsicker, L.G.2
Clarke, W.R.3
Berl, T.4
Pohl, M.A.5
Lewis, J.B.6
-
15
-
-
0027461994
-
Long-term effects of a converting enzyme inhibitor and a calcium channel blocker on urinary albumin excretion in patients with essential hypertension
-
Bigazzi R, Bianchi S, Baldari D, Sgherri G, Baldari G, Campese VM. Long-term effects of a converting enzyme inhibitor and a calcium channel blocker on urinary albumin excretion in patients with essential hypertension. Am J Hypertens 1993;6:108-13.
-
(1993)
Am J Hypertens
, vol.6
, pp. 108-113
-
-
Bigazzi, R.1
Bianchi, S.2
Baldari, D.3
Sgherri, G.4
Baldari, G.5
Campese, V.M.6
|